Evidence map›Paper›PMID 40009668›Full record

ArticleScience advances2025

Cryo-EM structure of the bacterial intramembrane metalloprotease RseP in the substrate-bound state.

Kikuko Asahi, Mika Hirose, Rie Aruga, Yosuke Shimizu, Michiko Tajiri, Tsubasa Tanaka, Yuriko Adachi, Yukari Tanaka, Mika K Kaneko, Yukinari Kato and 5 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Inhibitory proteins ofJournal of bacteriology · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kikuko AsahiGraduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.ORCID 0009-0000-1739-7620
Mika HiroseInstitute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka 565-0871, Japan.ORCID 0000-0001-8991-587X
Rie ArugaGraduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.ORCID 0009-0009-7620-0440
Yosuke ShimizuInstitute for Life and Medical Sciences, Kyoto University, 53 Shogoin kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.ORCID 0000-0002-0150-1582
Michiko TajiriGraduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.ORCID 0000-0001-7017-7993
Tsubasa TanakaGraduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.ORCID 0000-0003-3189-0352
Yuriko AdachiGraduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.ORCID 0009-0005-4011-1105
Yukari TanakaGraduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.
Mika K KanekoDepartment of Antibody Drug Development, Tohoku University Graduate School of Medicine; 2-1 Seiryo-machi, Sendai, Miyagi 980-8575, Japan.ORCID 0000-0002-4158-9208
Yukinari KatoDepartment of Antibody Drug Development, Tohoku University Graduate School of Medicine; 2-1 Seiryo-machi, Sendai, Miyagi 980-8575, Japan.ORCID 0000-0001-5385-8201
Satoko AkashiGraduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.ORCID 0000-0002-8978-6358
Yoshinori AkiyamaInstitute for Life and Medical Sciences, Kyoto University, 53 Shogoin kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.ORCID 0000-0003-4483-5408
Yohei HizukuriInstitute for Life and Medical Sciences, Kyoto University, 53 Shogoin kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.ORCID 0000-0003-0594-1160
Takayuki KatoInstitute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka 565-0871, Japan.ORCID 0000-0002-8879-6685
Terukazu NogiGraduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.ORCID 0000-0001-8663-3519

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Site-2 proteases (S2Ps), conserved intramembrane metalloproteases that maintain cellular homeostasis, are associated with chronic infection and persistence leading to multidrug resistance in bacterial pathogens. A structural model of how S2Ps discriminate and accommodate substrates could help us develop selective antimicrobial agents. We previously proposed that the

Indexed as

Bacterial ProteinsCryoelectron MicroscopyMembrane ProteinsMetalloproteasesCatalytic DomainCell MembraneEscherichia coliEscherichia coli ProteinsModels, MolecularProtein BindingProtein ConformationSubstrate SpecificityBacterial ProteinsEscherichia coli ProteinsMembrane ProteinsMetalloproteases

Identifiers

PMID40009668
PMCPMC11864173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.